CompletedPhase 4NCT00403611
Evaluation of Praziquantel Dosage for Treatment of Schistosomiasis in Brazil
Studying Schistosomiasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Oswaldo Cruz Foundation
- Principal Investigator
- Otavio S Pieri, PhDFundação Oswaldo Cruz
- Intervention
- Praziquantel 60 mg/kg(drug)
- Enrollment
- 196 enrolled
- Eligibility
- 10-19 years · All sexes
- Timeline
- 2006 – 2008
Collaborators
World Health Organization · Universidade Federal de Pernambuco
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00403611 on ClinicalTrials.govOther trials for Schistosomiasis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06698510Introduction of Arpraziquantel Treatment for Schistosomiasis Control in Preschool-aged Children in Endemic Areas: A Small-scale Public Health Intervention StudyPeter Steinmann
- RECRUITINGNANCT06873308Assessment of Infection Activity in Travelers and Migrants Diagnosed With Chronic SchistosomiasisIRCCS Sacro Cuore Don Calabria di Negrar